我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

微粒化非诺贝特调脂疗效的评价(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
1999年第2期
页码:
129
栏目:
短篇论文
出版日期:
1999-03-01

文章信息/Info

Title:
-
作者:
马 骥　俞　锋　单 江
浙江医科大学附属二院心内科　杭州 310009
Author(s):
-
关键词:
高脂血症　非诺贝特
Keywords:
-
分类号:
-
DOI:
-
文献标识码:
-
摘要:
-
Abstract:
-

参考文献/References

[1]Gastelli WP,Lipid,risk factors and ischemic heart disease.Atherosclerosis,1996;124 (suppl) : s1.

[2]Davignon J , Cohn JS. Triglycerides: a risk factor for coronary heart disease. Atherosclerosis, 1996; 124 ( supp l) : s57.

[3]Austin MA , KingMC,Vranizan KM , et al. Atherogenic lipoprotein phenotype a proposed genetic marker for coronary heart disease risk. Circulation, 1990; 82: 495.

[4]Dejager S,Brucker E, Chapam MJ. Dense low desity lipoprotein subsecies with diminished oxidative resistance predominate in combined hyperlipidemia. J Lipid Res, 1993; 34: 295.

[5]CastelliW P. Epidemiology of triglycerides: A view from Framingham. Am J Cardiol, 1992; 70: 3H.

[6]Voor AA ,Van Brussel BL , Kelder JC, et al. Usefulness of hypertriglyceridemia in predicting myocardial infarction late after coronary artery bypass operation. Am J Cardiol, 1997; 79 (10) : 1350.

[7]Chapaman MJ , Bruckert E. The atherogenic role triglycerides and small, dense low desity lipoproteins: impact of ciprofibrat therapy. Atherosclerosis, 1996; 124 (suppl) : s57.

备注/Memo

备注/Memo:
(收稿1998-05-14　修回1998-10-26)
更新日期/Last Update: 1999-03-01